Increased Fibroblast Growth Factor 23 in Heart Failure: Biomarker, Mechanism, or Both?

Nuria Garcia-Fernandez; Javier Lavilla; Paloma L Martín; Gregorio Romero-González; Arantxa González; Begoña López; Susana Ravassa; Javier Díez

doi:10.1093/ajh/hpy153

Increased Fibroblast Growth Factor 23 in Heart Failure: Biomarker, Mechanism, or Both?

Am J Hypertens. 2019 Jan 1;32(1):15-17. doi: 10.1093/ajh/hpy153.

Authors

Nuria Garcia-Fernandez^{1

2}, Javier Lavilla^{1

2}, Paloma L Martín^{1

2}, Gregorio Romero-González^{1

2}, Arantxa González^{2

3

4}, Begoña López^{2

3

4}, Susana Ravassa^{2

3

4}, Javier Díez^{1

2

3

4

5}

Affiliations

¹ Department of Nephrology, University of Navarra Clinic, University of Navarra, Pamplon, Spain.
² IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
³ Program of Cardiovascular Diseases, Centre of Applied Medical Research, University of Navarra, Pamplona, Spain.
⁴ CIBERCV, Carlos III Institute of Health, Madrid, Spain.
⁵ Department of Cardiology and Cardiac Surgery, University of Navarra Clinic, University of Navarra, Pamplon, Spain.

PMID: 30325410
DOI: 10.1093/ajh/hpy153

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Aldosterone
Biomarkers
Fibroblast Growth Factor-23
Fibroblast Growth Factors
Heart Failure*
Humans
Hypertension*
Renin

Substances

Biomarkers
Aldosterone
Fibroblast Growth Factors
Fibroblast Growth Factor-23
Renin